23 . November , 2017 - Thursday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Lansoprazole/Naproxen

Big Image Pronouncation: (lan-SOE-pra-zole/na-PROX-en)
Class: Non-narcotic analgesic combination

Trade Names:
Prevacid NapraPAC 500
- Tablets 15 mg lansoprazole/500 mg naproxen

Mechanism of Action



Suppresses gastric acid secretion by blocking acid (proton) pump within gastric parietal cells.


Decreases inflammation, pain, and fever, probably through inhibition of cyclooxygenase activity and prostaglandin synthesis.

Indications and Usage

For reducing the risk of NSAID-associated gastric ulcers in patients with a history of documented gastric ulcers who need an NSAID for treatment of signs and symptoms of rheumatoid arthritis, osteoarthritis, and/or ankylosing spondylitis.


Treatment of perioperative pain in the setting of coronary artery bypass graft (CABG) surgery; aspirin- or NSAID-related asthma, urticaria, or allergic-type reactions; hypersensitivity to any component of the product.

Dosage and Administration


PO Lansoprazole 15 mg once daily and naproxen 500 mg twice daily. The naproxen dose and frequency may be adjusted to meet the patient's needs.

General Advice

  • In the morning before eating, administer lansoprazole 15 mg and one naproxen 500 mg tablet. In the evening, administer the second naproxen 500 mg tablet.
  • Swallow lansoprazole capsules whole; do not crush or chew.


Store at 59° to 86°F. Protect from light and moisture.

Drug Interactions

ACE inhibitors, beta-blockers

Antihypertensive effect may be decreased by naproxen.


Risk of serious GI complications, including bleeding, may be increased.

Diuretics (eg, loop diuretics [eg, furosemide], thiazide diuretics [eg, hydrochlorothiazide])

Diuretic effect may be reduced.

Drugs in which gastric pH is an important determinant of bioavailability (eg, ampicillin esters, digoxin, iron salts, ketoconazole)

Absorption may be altered by lansoprazole (eg, absorption of digoxin increased and ketoconazole decreased).


Lithium levels may be elevated, increasing the risk of toxicity.


Naproxen plasma levels may be elevated and the t ½ may be prolonged.


Take lansoprazole at least 30 min prior to sucralfate.


Cl may be increased slightly.

Laboratory Test Interactions

Naproxen may falsely increase urinary 17-ketosteroid values; may interfere with urinary assays for 5-hydroxy-indolacetic acid, decrease platelet aggregation, and prolong bleeding times.

Adverse Reactions


Dizziness, drowsiness, headache, light-headedness, vertigo (1% to 10%); abnormal dreams, aseptic meningitis, cognitive dysfunction, depression, insomnia, malaise, speech disorder (postmarketing).


Edema, palpitations (1% to 10%); CHF, vasculitis (postmarketing).


Ecchymosis, pruritus, purpura, skin eruptions, sweating (1% to 10%); alopecia, erythema multiforme, photosensitivity (including cases resembling porphyria cutanea tarda), skin rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, urticaria (postmarketing).


Hearing disturbances, tinnitus, visual disturbances (1% to 10%); hearing impairment (postmarketing).


Abdominal pain, constipation, diarrhea, dyspepsia, flatulence, GI ulcers, gross bleeding/perforation, heartburn, nausea, stomatitis, vomiting (1% to 10%); colitis, hematemesis, nonpeptic ulceration, pancreatitis, ulcerative stomatitis (postmarketing).


Glomerular nephritis, hematuria, interstitial nephritis, menstrual disorder, nephrotic syndrome, renal disease, renal failure, renal papillary necrosis, urinary retention (postmarketing).


Agranulocytosis, aplastic anemia, eosinophilia, granulocytopenia, hemolytic anemia, leukopenia, melena, neutropenia, pancytopenia, thrombocytopenia, thrombotic thrombocytopenic purpura (postmarketing).


Abnormal LFTs, hepatotoxicity, jaundice (postmarketing).


Hyperglycemia, hyperkalemia, hypoglycemia (postmarketing).


Muscle weakness, myalgia, myositis (postmarketing).


Dyspnea (1% to 10%); eosinophilic pneumonitis (postmarketing).


Thirst (1% to 10%); anaphylactic reactions, angioneurotic edema, pyrexia (postmarketing).



NSAIDs may cause an increased risk of serious CV thrombotic events, MI, and stroke, which can be fatal. This risk may increase with length of therapy. Patients with CV disease or risk factors for CV disease may be at greater risk. Naproxen is contraindicated for the treatment of perioperative pain in the setting of CABG surgery. NSAIDs cause an increased risk of serious GI adverse reactions, including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These reactions can occur any time during use and without warning symptoms. Elderly patients are at greater risk of serious GI reactions.


Determine hemoglobin values periodically in patients with an initial hemoglobin value of 10 g or less who receiving long-term therapy.


Category C . Avoid use in late pregnancy; may cause premature ductus arteriosus closure.



Excreted in breast milk.




Safety and efficacy not established.

Renal Function

Naproxen-containing products are not recommended in patients with moderate to severe and severe renal function impairment (Ccr less than 30 mL/min).

Hepatic Function

Consider dosage adjustments for the naproxen component in elderly patients and patients with liver disease.

Special Risk Patients

Use with caution in elderly patients or patients with fluid retention, hypertension, heart failure, or history of GI bleeding or ulcer disease.


Bleeding time may be prolonged as a result of inhibition of platelet aggregation.

Concomitant therapy

Do not use naproxen sodium with other naproxen-containing drugs because they all will circulate as naproxen anion.


Onset of new hypertension or worsening of preexisting hypertension may occur, increasing the risk of CV events.

Inflammatory conditions

Because fever and inflammation may be reduced by naproxen, signs used in diagnosing complications of presumed noninfectious, noninflammatory painful conditions may be diminished.

Renal effects

Long-term administration may result in renal injury, including renal papillary necrosis.



Abdominal discomfort, acute renal failure, alterations in liver function, anaphylactoid reactions, apnea, coma, disorientation, dizziness, drowsiness, epigastric pain, GI bleeding, heartburn, hypertension, hypoprothrombinemia, indigestion, lethargy, metabolic acidosis, nausea, renal function impairment, respiratory depression, seizures, vomiting.

Patient Information

  • Advise patient to read the Medication Guide before starting therapy and with each refill.
  • Instruct patient to take lansoprazole 15 mg and one naproxen 500 mg tablet in the morning before eating and to take the second naproxen 500 mg tablet in the evening.
  • Instruct patient to promptly report signs or symptoms of unexplained weight gain or edema to health care provider.
  • Instruct patient of the warning signs and symptoms of hepatotoxicity and to stop therapy and seek immediate medical attention if they occur.
  • Instruct patients to seek immediate medical assistance if they experience difficulty breathing and/or swelling of the face or throat.
  • Caution patient to avoid taking this medication in late pregnancy because of risk of premature closure of the ductus arteriosus.
  • Advise patients to use caution when engaging in activities requiring alertness if they experience drowsiness, dizziness, vertigo, or depression during therapy.

Recent Drug Updates at DrugIndexOnline:

Brethine Tablets Brethine Tablets
Generic Name: Terbutaline Tablets (ter-BYOO-tuh-leen) Brand Name: BrethineBrethine is used for:Treating or preventing symptoms caused by spasms or contractions of the muscles around the bronchioles (air tubes) associated with asthma, bronchitis, and emphysema. It may also be used for other condi more...

Dipentum Dipentum
Generic Name: olsalazine (ole SAL a zeen) Brand Names: Dipentum What is Dipentum (olsalazine)? The exact way that olsalazine works is unknown, but it is believed to reduce the actions of a substance in the body that causes inflammation, tissue damage, and diarrhea. Olsalazine is used to more...

Ex-Lax Extra Strength Ex-Lax Extra Strength
Some commonly used brand names are: In the U.S.— Agoral 35 Alophen 25 Alphamul 30 Alramucil Orange 7 Alramucil Regular 7 Bisac-Evac 25 Black-Draught 26 Black-Draught Lax-Senna 32 Carter's Little Pills 25 Cholac 14 Citroma 16 Citrucel Orange Flavor 3 Citrucel Sugar-Free Orange Flavor 3 Col more...

Floctafenine Floctafenine
Some commonly used brand names are: In the U.S.— Actron 9 Advil 7 Advil Caplets 7 Advil, Children's 7 Aleve 14 Anaprox 14 Anaprox DS 14 Ansaid 6 Bayer Select Ibuprofen Pain Relief Formula Caplets 7 Cataflam 1 Clinoril 18 Cotylbutazone 16 Cramp End 7 Daypro 15 Dolgesic 7 Dolobid 2 EC-Napro more...

Genasoft Genasoft
Generic Name: docusate (DAH cue sate) Brand Names: Aqualax, Calube, Colace, Colace Micro-Enema, Correctol Softgel Extra Gentle, DC-240, Dialose, Diocto, Dioctocal, Dioctosoftez, Dioctyn, Dionex, Doc-Q-Lace, Docu Soft, Docucal, Doculax, Docusoft S, DOK, DOS, Doss-Relief, DSS, Ex-Lax Stool more...

Mepenzolate Mepenzolate
Generic Name: Mepenzolate (me-PEN-zoe-late) Brand Name: CantilMepenzolate is used for:Treating ulcers, in combination with other medicines. It may also be used for other conditions as determined by your doctor. Mepenzolate is an anticholinergic. It works by decreasing stomach acid production a more...

Oxprenolol Oxprenolol
Some commonly used brand names are: In the U.S.— Betapace 13 Blocadren 14 Cartrol 5 Corgard 8 Inderal 12 Inderal LA 12 Kerlone 3 Levatol 10 Lopressor 7 Normodyne 6 Sectral 1 Tenormin 2 Toprol-XL 7 Trandate 6 Visken 11 Zebeta 4 In Canada— Apo-Atenolol 2 Apo-Metoprolol 7 Apo-Metopro more...

Prazepam Prazepam
Some commonly used brand names are: In the U.S.— Alprazolam Intensol 1 Ativan 12 Dalmane 9 Diastat 7 Diazepam Intensol 7 Dizac 7 Doral 16 Halcion 18 Klonopin 5 Librium 3 Lorazepam Intensol 12 Niravam 1 Paxipam 10 ProSom 8 Restoril 17 Serax 14 Tranxene-SD 6 Tranxene-SD Half Strength 6 Tran more...